Cargando...
Therapeutic strategies with oral fluoropyrimidine anticancer agent, S-1 against oral cancer()
Oral cancer has been recognized as a tumor with low sensitivity to anticancer agents. However, introduction of S-1, an oral cancer agent is improving treatment outcome for patients with oral cancer. In addition, S-1, as a main drug for oral cancer treatment in Japan can be easily available for outpa...
Gardado en:
| Publicado en: | Jpn Dent Sci Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5501734/ https://ncbi.nlm.nih.gov/pubmed/28725297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdsr.2016.11.001 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|